Axsome Therapeutics Inc

Regional Account Manager- Neurology (Mississippi Valley Based Candidates)

Mississippi, United States

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, NeurologyIndustries

Position Overview

  • Company: PTC (Perceptual Therapeutics)
  • Industry: Pharmaceuticals/Biotech
  • Location Type: Remote (Based in New Orleans, Memphis, Little Rock, or Jackson)
  • Job Type: Full Time
  • Salary: Not specified

The Regional Account Manager is directly responsible for representing PTC’s products to medical professionals specializing in the diagnosis and treatment of neurological diseases and/or Friedreich's Ataxia (FA) within their assigned region. The incumbent handles all operational aspects of pharmaceutical sales and services, including generating sales, communicating and promoting the product's clinical and economic benefits, building and maintaining successful relationships, educating healthcare staff, and identifying new opportunities for commercial and scientific growth. This role works cross-functionally with internal departments and external resources on Sales-related issues and supports adherence to relevant regulatory requirements and company Standard Operating Procedures (SOPs).

Responsibilities

  • Achieve assigned sales targets in a compliant manner and contribute to the overall success of the metabolism business unit.
  • Implement marketing strategies to meet sales and patient objectives for neurology and/or FA products on a monthly, quarterly, and yearly basis.
  • Collaborate within a matrix environment, engaging with Patient Services, Patient Engagement, Marketing, Managed Markets, and Medical Affairs.
  • Develop business partnerships with targeted physicians and healthcare staff, understanding their needs and discussing how PTC products and resources meet these needs.
  • Identify key treatment centers and facilities. Collaborate across centers and with their stakeholders to optimize patient care.
  • Establish and maintain relationships with patient and disease-focused advocacy groups.
  • Employ a consultative, solution-oriented sales approach tailored to healthcare professionals treating patients with neurological diseases and/or FA.
  • Address and resolve product access and reimbursement issues.
  • Cultivate relationships with key thought leaders in the neurology and/or FA therapeutic area.
  • Perform additional tasks and assignments as needed and specified by management.

Requirements

  • Education:
    • Bachelor’s degree required.
    • Degrees in life sciences, business, or healthcare are preferred.
  • Experience:
    • Minimum of 5 years of pharmaceutical, biotech, or healthcare sales experience.
    • Minimum of 3 years of rare disease, orphan drug, or highly specialized sales experience.
    • Experience selling high-cost products distributed through a specialty pharmacy requiring extensive coordination with patient services.
  • Skills:
    • Proven track record of exceeding sales targets and successfully growing and managing a territory in prior roles.
    • Previous selling experience in specialized clinics, hospitals, and academic centers, including the ability to perform complete account selling.
    • Demonstrated ability to analyze complex technical data and to develop strategies.

Skills

Pharmaceutical sales
Neurology
Friedreich's Ataxia
Relationship building
Healthcare education
Regulatory compliance
Cross-functional collaboration
Solution-oriented sales

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI